Advertisement

Palliative and End-of-Life Care

The Role of the Pharmacist

Palliative and End-of-Life Care

Pharmacotherapy is key component of palliative care and pharmacists trained in this specialty also play critical roles in communicating with patients and their families, ensuring comfort, and providing education and emotional support. Pharmacists employ their knowledge of regulatory requirements to facilitate access to needed pain medications, avoid interruptions in care, and ensure safe storage and disposal of unused medications. Pharmacists can also use their medication expertise to avoid adverse drug events in a patient population that is characterized by multiple co-morbidities, including heart failure, chronic obstructive pulmonary disease, HIV infection, and neurological disease.

Examples of Transformational Change in Pharmacy Practice

Below are highlights of the important role pharmacists play in improving palliative and end-of-life care:

Hospice Care: A descriptive study of 87 drug-related problems identified by pharmacists with specialty training in hospice care found that among the clinical interventions recommended by pharmacists 84% were accepted by the prescriber and 85% were described as helpful in achieving the desired therapeutic goal. See Lee J and McPherson ML. Outcomes of recommendations by hospice pharmacists. Am J Health-Syst Pharm. 2006; 63:2235-9.

Geriatric Care: A randomized controlled trial evaluated the extent to which clinical pharmacists’ consultation lead to improvement in appropriate drug prescribing for geriatric patients. Pharmacists reviewed hospital records and drug regimens to assess the appropriateness of prescribing and consulted with patients to reinforce physician instructions, enhance patient’s knowledge and motivation, and provide resources to facilitate adherence. more Read more

Palliative Care: In an evaluation of 130 interventions provided to 25 patients by community pharmacists trained in palliative pharmaceutical care, an interdisciplinary expert panel found that 81% of the interventions were likely to be beneficial. See Needham D. Evaluation of the effectiveness of UK community pharmacists’ interventions in community palliative care. Palliat Med. 2002; 16:219-25.

Relevant ASHP Best Practices

Other ASHP Resources

 

Previous Priority

 

Advertisement